News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - Patent News
Courtagen Receives Notice Of Allowance For A Genetically Targeted Pain Therapy Patent In The U.S. 2/23/2017
Soligenix (SNGX) Receives European Patent For Formulation Of Synthetic Hypericin To Treat Psoriasis 2/22/2017
Cleveland HeartLab LLC Adds New Patent To Its Extensive Intellectual Property Position For The Myeloperoxidase (MPO) Test, A Powerful Biomarker For Inflammation And Its Role In Major Cardiac Events 2/22/2017
How Much Is a CRISPR Patent License Worth? 2/21/2017
RDD Pharma Announces Patents Granted In Israel And EU 2/21/2017
Eagle Pharma (EGRX) Announces New Patents Issued For Bendeka 2/21/2017
Renova Therapeutics Release: U.S. Patent For Urocortin 2 Gene Constructs Issued 2/21/2017
The Winners And Losers In The CRISPR Patent Fight 2/16/2017
This is Why the Decision on Who Invented CRISPR Matters 2/16/2017
Symbiotix Biotherapies Announces Issuance Of First Composition Of Matter Patent Covering A Microbiome-Derived Therapeutic Molecule 2/16/2017
CRISPR (CRSP), Intellia, Caribou Biosciences And ERS Genomics Provide Update On CRISPR/Cas9 U.S. Patent Interference Proceedings And Grants Of Corresponding Patents In The U.K. 2/16/2017
Spectro Scientific Wins U.S. Patent For Water Contamination Measurement Method Used In Its FluidScan Handheld Infrared Oil Analyzer 2/16/2017
Insmed (INSM) Extends ARIKAYCE Intellectual Property Protection With Issuance Of New U.S. Patent 2/14/2017
ITL Pharma Receives United States Patent Protection For Trithroid Using Sustained Drug Release And Improved Product Stability 2/14/2017
Armetheon Announces Issuance Of A New U.S. Patent For Its Phase 2 Clinical Stage Novel Oral Anti-Arrhythmic Budiodarone 2/13/2017
Onxeo Receives USPTO Notice Of Allowance For A new AsiDNATM-Related Patent, Expanding Its IP Protection In The U.S. 2/13/2017
Koios Receives Favorable Ruling In Challenge To High-Cost Drug’s Patent 2/10/2017
ADM Tronics (ADMT) Launches Major Expansion Of Medical Device Design And Engineering Capabilities 2/10/2017
Replicel Life Sciences Announces European Patents For Its Innovative Dermal Injector Technologies 2/9/2017
SpinalCyte, LLC Announces New U.S. Patent 2/9/2017
Supernus (SUPN) Announces Issuance Of Eighth U.S. Patent Protecting Trokendi XR 2/8/2017
Perrigo (PRGO) Confirms Patent Challenge For Generic Version Of Onexton Gel 2/7/2017
Emmaus Life Sciences Receives Notice Of Allowance For Japanese Patent For Use Of L-Glutamine In Treatment Of Diabetes 2/7/2017
Sirbal To Receive Its Seventh Allowable US Patent 2/7/2017
TapImmune (TPIV) Expands Intellectual Property On PolyStart Platform For Use In Next-Generation T-Cell Vaccines 2/7/2017
Ace Laboratories Announces Licensing Of Resveratrol Patents 2/7/2017
Arch Therapeutics Announces Issuance Of Method-Of-Use Patent Covering Self-Assembling Peptidomimetics 2/3/2017
Teva (TEVA) Confirms Generic Victoza Patent Challenge In The United States 2/2/2017
Are Teva (TEVA)'s Best Days Behind It? 2/2/2017
How A 2015 Trial Sheds Light On The CRISPR Patent Case 2/2/2017
Emmaus Life Sciences Receives Notice Of Allowance For U.S. Patent For Use Of L-Glutamine In Treatment Of Diverticulosis 2/1/2017
Kitov (KTOV) Granted Notice Of Allowance From U.S. Patent & Trademark Office For KIT-302 2/1/2017
Bristol-Myers Squibb (BMY) Announces European Patent Office Decision On Sprycel 2/1/2017
Mylan (MYL) Wins U.S. District Court Ruling Related To Copaxone 40 mg/mL Patents 1/31/2017
Tyme Announces Issuance Of Second Core Platform Patent 1/31/2017
Momenta (MNTA) Announces District Court Decision To Invalidate Teva (TEVA) Patents In COPAXONE (Glatiramer Acetate Injection) 40 Mg/Ml Litigation 1/31/2017
Dimerix Key Patent Allowed In Japan For Use Of Lead Drug Candidate In The Treatment Of Kidney Disease 1/31/2017
Teva (TEVA) Confirms District Court Decision In COPAXONE 40 mg/mL Patent Trial 1/31/2017
Zogenix (ZGNX) Announces Issuance Of U.S. Patent for ZX008 In Dravet Syndrome 1/30/2017
Supernus (SUPN) Announces Issuance Of Seventh U.S. Patent Protecting Trokendi XR 1/30/2017
Vybion, Inc. Huntington's Disease Drug Patent Receives Track I Status 1/30/2017
Absorption Systems Release: U.S. Patent Issued For Company' IDAS2, A First-In-Class Test System For Fundamental Drug Properties 1/26/2017
Knopp Biosciences Release: Company Receives Key Patent Directed To Ion Channel Activators For Brain Disorders 1/26/2017
SIRAKOSS Release: UK Based Medical Device Company Announces Two New Patents Granted By The US Patent And Trademark Office 1/26/2017
Humanetics Release: Pharma Awarded Patent To Mitigate Erectile Dysfunction Associated With Prostate Cancer Radiotherapy 1/24/2017
Cellectar Biosciences  (CLRB) Release: Company Announces Additional U.S. Patent Granted For CLR 131 And CLR 125 In A Broad Range Of Solid Tumors 1/24/2017
Propanc Release: Company Provides Progress Update On Additional Patent Applications 1/24/2017
Aushon Biosystems Release: New U.S. Patent Allowance Granted To Company For Microarray Printing Of Complex Biological And Chemical Fluids 1/24/2017
EyeGate Pharma Release: Company Awarded Canadian Patent For Proprietary Iontophoretic Formulation And Use Of The Formulation For Ocular Delivery Of Dexamethasone Phosphate 1/23/2017
10X Genomics Release: Company Invalidates RainDance Technologies Patent 1/23/2017
Zenosense (ZENO) Release: New Patent Application For Additional MIDS Detection Method 1/23/2017
Vaxil BioTherapeutics Release: Company Expands Into Infectious Diseases With First U.S. Patent For MTbuVax 1/20/2017
Why Patent Protection In The Drug Industry Is Out Of Control 1/19/2017
Biocept, Inc. (BIOC) Release: Company Awarded Patent In Australia For The Use Of Antibodies In Microchannels To Capture Circulating Tumor Cells And Other Rare Cells 1/19/2017
Mithra Pharmaceuticals Release: Company Announces Us Patent Allowance For The Use Of Estetrol As Emergency Contraceptive 1/18/2017
Oncoinvent AS Patent Issues In The USA 1/18/2017
Cephalogics Awarded A U.S. Patent For Its High-Density Diffuse Optical Tomography System 1/17/2017
Carestream Health Release: Company’s Successful R&D Efforts Earn 43 U.S. Patents During 2016; 52 Additional Patents In Other Countries 1/17/2017
EyeTracking Release: Company Issued Key Patent 1/17/2017
joimax Release: Company Shows Strong Growth Trend Again In 2016 And Is Issued New Patents, The Company Now Holds Than 150 Patents And Trademarks Worldwide 1/16/2017
MonoSolRx LLC Release: Company Files Patent Infringement Suit Against BioDelivery (BDSI) 1/16/2017
Osseon Release: Company Receives New Patent 1/13/2017
Biotech Support Group Release: Patent Cites HemogloBind In Complement Mediation 1/12/2017
M Pharmaceuticals Release: Company Announces Plans To Develop A Drug Product For Treatment Of FSD 1/12/2017
Aralez Release: Pharma Announces Issuance Of Additional U.S. Patent For Yosprala 1/11/2017
LKC Technologies Release: Meddevice Company's Portable RETeval Electrodiagnostic Device and Sensor Strips Earn Two United States Patents 1/11/2017
Propanc Release: Company Receives Allowance Of Key Patent Application For Method Of Treating Solid Tumors In The U.S. 1/11/2017
Santalis Announces Notice Of Allowance Of A U.S. Patent For The Use Of East Indian Sandalwood Oil To Treat Clostridium Infections 1/9/2017
Court Grants Permanent Injunction For Infringement Of Amgen (AMGN)'s Repatha Patents 1/9/2017
Celyad Announces USPTO Decision To Uphold U.S. Patent For Production Of Allogeneic TCR-Deficient CAR-T Cells 1/9/2017
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice Of Acceptance for Patent in Australia For Treatment of Neural Injury with Thymosin Beta 4. 1/9/2017
Amgen (AMGN) Shares Soar After Blocking Rivals From Selling Competing Cholesterol-Lowering Drug 1/6/2017
Iroko Pharma Announces Key Patent For VIVLODEX 1/6/2017
IMPAX Labs (IPXL) Confirms Patent Challenge Relating To Generic Aubagio (Teriflunomide) Tablets, 14 Mg 1/6/2017
Ascendia Pharmaceuticals Announces Issuance Of A New Patent On Its ASD-002 Program For Acute Coronary Syndrome 1/6/2017
SpinalCyte, LLC Receives New U.S. Patent 1/6/2017
Key Patent Is Issued Covering Protagonist (PTGX)' Alpha4Beta7 Integrin Peptide Inhibitors Including Oral Drug Candidate PTG-100 1/5/2017
Deinove Release: A First Innovative Antibiotic Candidate Patented 1/5/2017
Twenty-two New Patents Are Added To ViaCyte's Intellectual Property Portfolio 1/4/2017
Verseon (VSN.L) Granted U.S. Patents Covering Its Novel Serine Protease Inhibitors 1/4/2017
Sanofi (SNY), Regeneron (REGN) Lose Bid To Overturn Amgen (AMGN) Win In Patent Case 1/4/2017
Knopp Biosciences Receives Key Patent Directed To Treatment For Hypereosinophilic Syndromes, Asthma, And Other Eosinophilic Diseases 1/4/2017
Teewinot Life Sciences' Irish Subsidiary Full Spectrum Laboratories, Ltd. Secures A New U.S. Patent For Biosynthesis Of Cannabinoids 1/3/2017
Avenue Therapeutics Receives Notices Of Allowance For Patent Applications Covering Methods Of Administration For Intravenous Tramadol 1/3/2017
Drug Patents Expiring In 2017? It’s All Smoke And Mirrors 1/3/2017
Marina Biotech (MRNA) Granted European Claims Covering Bacteria Mediated Gene Silencing 1/3/2017
BioCardia Receives Another U.S. Patent Covering A Method Of Treating Heart Attack Tissue Damage With A Patient’s Own Progenitor Cells, Providing Further Protection To Phase III CardiAMP Program 12/27/2016
IntelliPharmaCeutics Announces Issuance Of U.S. And Canadian Patents Covering Aspects Of Its PODRAS Overdose Technology 12/21/2016
Ogeda Announces Fezolinetant As INN And Issuance Of U.S. Patent For ESN364 12/20/2016
Cellectar Biosciences  (CLRB) Announces US And Japanese Patent Allowances For Diagnostic And Optical Imaging PDCs 12/20/2016
Leonhardt And Genovese File Patent For Bioelectric Controlled Expression Of PDGF A Powerful Organ Regeneration Cytokine 12/20/2016
Kite Pharma (KITE) Announces Successful Defense Of Roberts Patent And Intent To Appeal U.S. Patent And Trademark Office Decision On A Narrow Patent Focused On Select CD28 CAR-T Products 12/19/2016
Pulmatrix Receives Patents Important To Its Inhaled Drug Delivery Technology 12/19/2016
Pivotal Evolva (EVE.SW) Stevia Sweetener Patent Receives U.S. Notice Of Allowance 12/19/2016
NanoBio Corporation Awarded U.S. Patent For RSV Vaccine 12/19/2016
Gilead (GILD) Sinks, Will Pay Rival $2.54 Billion for a Patent Dispute 12/19/2016
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice Of Intent To Grant Patent In EU For Treating Neural Injury With Thymosin Beta 4 12/16/2016
Regen BioPharma Files Utility Patent Application On NR2F6-Silenced CAR-T Cell For Solid Tumors 12/15/2016
DelMar Pharma Receives Notice Of Allowance From The US Patent And Trademark Office For Key Patent For VAL-083 12/14/2016
Cellectar Biosciences  (CLRB) Announces USPTO Grants Patent Allowances For Radiotherapeutic Pdcs For A Variety Of Solid Tumor Types 12/14/2016
BioCardia Receives U.S. Patent Covering A Method Of Treating Heart Attack Tissue Damage With A Patient’s Own Progenitor Cells, Providing Further Protection To Phase III Cardiamp Program 12/14/2016
TxCell Provides Update On Its Strengthened IP Portfolio 12/14/2016
GB Sciences Licenses Patent To Develop New Cannabis-Based Therapies For The Treatment Of Heart Disease 12/13/2016
Emmaus Life Sciences Receives Japanese Patent For Use Of L-Glutamine In Treatment Of Diverticulosis 12/13/2016
Synthetic Biologics (SYN) Announces Granting Of U.S. Composition Of Matter Patent For SYN-005, Designed For The Treatment And Prevention Of Pertussis (Whooping Cough) 12/13/2016
Creative Medical Technology Files Patent On AmnioStem Stroke Therapy 12/13/2016
Cellectar Biosciences  (CLRB) Announces USPTO Grants Patent For Paclitaxel PDC; Provides Additional Patent Protection For Select Solid Tumors Through 2035 12/12/2016
Medizone Release: AsepticSure Hospital Disinfection System Expands North American Patent Coverage 12/12/2016
Akebia (AKBA) Prevails in Additional European Patent Dispute 12/12/2016
Bodycad Awarded Key US Patents For Improving Accuracy, Reproducibility And Speed For 3D Imaging In Orthopaedic Applications 12/9/2016
Allergan (AGN) Comments On PTAB Decision Regarding Mylan (MYL)'s Petitions For Inter Partes Review (IPR) Of RESTASIS Patents 12/8/2016
Vanda (VNDA) Settles Fanapt Patent Litigation Wth Apotex 12/8/2016
Orexo (ORXOF) Appeal Zubsolv US District Court Decision 12/8/2016
Key Synaffix Patent Covering Glycan-Conjugated ADC Process Granted In The United States 12/8/2016
Who Owns CRISPR—One Of The Most Important Genetic Inventions Of Our Time? 12/7/2016
Perflow Announces Issuance Of Patent For The Stream Dynamic Neuro-Thrombectomy Net To Improve Thrombus Removal Post-Stroke 12/7/2016
Egalet Announces Issuance Of New Patent For Egalet-002 And Guardian Technology 12/6/2016
Teewinot Life Sciences' Irish Subsidiary Full Spectrum Laboratories, Ltd. Secures A New U.S. Patent Covering An Apparatus For Biosynthetic Production Of Authentic THCA, CBDA And CBCA Cannabinoids 12/6/2016
CohBar Continues Exploration Of Mitochondrial Genome And Expansion Of Its IP Portfolio With Filing Of 29 New Provisional Patents 12/6/2016
Renovacare Awarded U.S. Patent For SkinGun Device To Spray Stem Cells On To Wounds 12/6/2016
New Patent Infringement Lawsuit Filed Against Alcatel-Lucent Under Spherix (SPEX) Collaboration Agreement 12/5/2016
Allergan (AGN) Announces Settlement Of A DELZICOL (Mesalamine) Patent Litigation 12/2/2016
Pharmazz Advances Its Product Pipeline For The Treatment Of Stroke, Strengthens Patent Portfolio And Presents Hemorrhagic Shock Data At The AHA 11/30/2016
Onxeo Strengthens AsiDNA Patent Protection In Europe 11/30/2016
Zivo Bioscience, Inc. Granted New US Patent For Healthy Cholesterol Balance 11/30/2016
SomaGenics Inc. Granted New Patents For RNA Detection And RNA-Based Therapeutics Technologies 11/29/2016
Nevro Files Lawsuit For Patent Infringement Against Boston Scientific (BSX) In The U.S. 11/29/2016
Akorn, Inc. (AKN) Invalidates Durezol Patent Via Inter Partes Review Proceeding 11/29/2016
SYGNIS Reinforces Its Proteomics Portfolio With Two Patents Granted In Europe And China 11/28/2016
Persavita Receives U.S. Patent For Unique Saffron 2020 Eye Health Formula 11/23/2016
Immunomic Announces Expansion Of IP Portfolio 11/22/2016
Another iBio, Inc. (IBIO) Plague Vaccine Patent Issues 11/22/2016
Propel Moves To Cancel Competitor's Patents 11/22/2016
The 27-Year Old Who Blew Up Theranos is the Grandson of a Company Director 11/21/2016
Ruling Affirms Patent Claim For Paragon BioTeck's R-Phenylephrine Hydrochloride Formulation 11/21/2016
iX Biopharma Secures South African Patent For Waferix Drug Delivery Technology 11/21/2016
Egalet Announces OXAYDO Receives Pharmaceutical Composition Patent Protection Through 2024 11/17/2016
Silk Therapeutics Release: Silk Scientists Advance Natural Liquid Silk, Granted Five Patents Covering 75+ Claimed Pure Silk Formulations 11/17/2016
New U.S. Patent Allowance Granted To Axim Biotech For Use Of All Cannabinoids In Its Controlled-Release Chewing Gum Products 11/16/2016
Proclara Announces Newly Issued U.S. Patents For Its Core Technology Targeting Protein Misfolding Disorders 11/16/2016
Cytori (CYTX) Strengthens Global Intellectual Property Portfolio With Key Patents 11/16/2016
USPTO Issues Patent For "Preservation By Vaporization" Technology, Allowing Manufacture Of Thermostable Vaccines And Other Fragile Biopharmaceuticals 11/16/2016
Orexo (ORXOF): Favorable Outcome From Zubsolv Patent Infringement Litigation Against Actavis (ACT) 11/16/2016
Senhwa Biosciences Files New Patent Applications For Use Of CX-5461 In Combination With PARP Inhibitors, PI3K And Immunotherapeutic Agents 11/15/2016
Absorption Systems Receives U.S. Patent For IDAS2, A Groundbreaking Test System For Fundamental Drug Properties 11/14/2016
Actinium (ATNM.OB) Announces Notice Of Allowance For U.S. Patent Related To Actimab-A 11/14/2016
Expanding Orthopedics Inc. Granted A New US Patent For Its Unique 3D Expandable Cage 11/14/2016
ArcherDX Release: Anchored Multiplex PCR Patent Is Issued To Inventors At Massachusetts General Hospital 11/14/2016
Vitality Biopharma Announces International Patent Filing For Cannabinoid Pharmaceuticals 11/11/2016
Synlogic Secures Patent On Proprietary Synthetic Probiotic Bacteria For The Treatment Of Hyperammonemia 11/10/2016
Can-Fite BioPharma (CFBI) Receives Notice Of Allowance From U.S. Patent And Trademark Office For Erectile Dysfunction Drug 11/10/2016
BRH Medical Receives Patents In Both The USA And In China For Its Innovative Wound Healing Therapy 11/9/2016
CureVac Receives Broad Patent For RNAntibody Technology 11/9/2016
Lipocine (LPCN) Announces Issuance Of US Patent 9,480,690 11/7/2016
Karolinska Development AB Modus Therapeutics Granted U.S. Patents For Sickle Cell Disease Drug Candidate Sevuparin 11/7/2016
Progress In Videregen's Patent Portfolio On Biological Scaffolds For Replacement Organs 11/7/2016
TrovaGene (TROV) Announces HPV Patent Issuance By U.S. Patent And Trademark Office, Broadening Its Precision Cancer Monitoring IP Portfolio 11/7/2016
MabVax Therapeutics Receives U.S. Patent For Its Clinical Stage HuMab-5B1 Antibody 11/7/2016
Atlantic Healthcare Granted U.S. Patent Extending IP Cover Of Alicaforsen In The Treatment Of Inflammatory Bowel Disease 11/7/2016
Spotlight Innovation Expands Its Patent Estate Of Snake Venom-Derived Therapeutics 11/4/2016
Celyad CEO Accuses Cellectis (ALCLS)' Leader of Lying About CAR-T Patent 11/4/2016
Atriva Therapeutics Announces Upcoming U.S. Patent Issuance For MEK Treatment Against Viral Diseases 11/4/2016
AngioSoma To Upgrade Its Omnicath Patents Into Omnicath 2 Atherectomy Catheter 11/4/2016
Creative Medical Technology Receives Exclusive License To Key Amniotic Fluid Stem Cell Patent From University Of California System 11/3/2016
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Notice Of Allowance For Patent For Tß4 Eye Drop Formulation 11/3/2016
DiscGenics, Inc. Fortifies Its Intellectual Property Portfolio With 9 Additional Patents 11/3/2016
Entia Biosciences Receives Notification Of The Grant Of European Patent It Has Exclusively Licensed For Identifying The Ergothioneine Transporter And Its Therapeutic Uses 11/3/2016
InDex Pharmaceuticals AB Gets New Patent Granted In The U.S. 11/3/2016
Exco InTouch Granted U.S. Patent For Its Ground-Breaking Mobile Health Solutions 11/2/2016
USITC Finds In Favor Of Varian Medical Systems (VAR) In Patent Dispute On VMAT Technology 11/1/2016
Fractal Antenna Systems Release: Key Metamaterial Patent Issued Using Fractals 11/1/2016
BrainStorm Cell Granted United States Patent For Its Stem Cell Technology 10/31/2016
iX Biopharma Secures Canadian Patent For Waferix Drug Delivery Technology 10/31/2016
Faron Pharmaceuticals Ltd. Release: New Patent Application Accepted By Finnish Patent Office 10/31/2016
Intec Pharma Granted Chinese Patent For Accordion Pill Carbidopa/Levodopa 10/31/2016
Starpharma: Additional Priostar Glyphosate Patent Allowed In U.S. 10/28/2016
Mati Therapeutics Expands Intellectual Property Portfolio 10/26/2016
Vanda (VNDA) Settles Fanapt Patent Litigation With Taro (TARO) 10/25/2016
TheraCell And AlloSource Announce Issuance Of Patent For Bone Fiber Technology 10/25/2016
Matinas BioPharma Receives Notice Of Allowance Of U.S. Patent For Novel Lipid-Crystal Nano-Particle Cochleate Formulation Technology 10/24/2016
Personal Genome Diagnostics Licenses Rights To Microsatellite Instability (MSI) Testing Technology From Johns Hopkins University To Inform Immunotherapy 10/20/2016
Relmada Therapeutics Announces Issuance Of Key U.S. Patent Covering D-Methadone, An NMDA Receptor Antagonist, For The Treatment Of Depression And Other Psychiatric Symptoms 10/20/2016
Entest Biomedical, Inc.'s Zander Therapeutics Unit Files Composition Of Matter Patent On NR2F6 Modulating Small Molecules In Canine And Feline Applications 10/20/2016
Key Metamaterial Patent To Fractal Antenna Systems 10/19/2016
Spherix (SPEX) Launches New Patent Licensing Initiative 10/19/2016
Mallinckrodt (MNK): European Patent Granted For BUPI 10/19/2016
Vedanta Biosciences Granted First European Patent Broadly Covering Pharmaceutical Compositions For Microbiome Therapeutics Based On Bacterial Consortia 10/19/2016
NeuroRx Solidifies Intellectual Property Position - Receives Notice Of Allowance By US Patent Office 10/18/2016
Gentag's Lab-On-A-Chip (LOC) Patent For Diagnostics With Cell Phones Issues 10/18/2016
RedHill Biopharma (RDHL) Announces Allowance Of A Patent In Japan Supporting RHB-104 For Multiple Sclerosis 10/18/2016
Spherix (SPEX) Provides Update On Patent Infringement Litigation 10/17/2016
Metacrine Expands Patent Portfolio For Novel FGF-1 Program To Treat Diabetes 10/17/2016
Relburn-Metabolomics Files Patents On Bifunctional Nanomolar Inhibitors Of Gout Target Enzymes 10/17/2016
Clarus Therapeutics Provides Update On Patent Infringement Lawsuit Against Lipocine (LPCN)'s Oral Product For Testosterone Replacement Therapy 10/13/2016
RenovoRx Announces The U.S. Patent And Trademark Office Issuance Of Two Patents 10/13/2016
CohBar Announces Discovery Of New Peptides In The Mitochondrial Genome 10/13/2016
MicroBiome Therapeutics LLC' Nm504 For Improving Blood Glucose Regulation Is First Microbiome Modulator To Receive U.S. Patent Allowance 10/12/2016
Rebiotix Receives Patent From The USPTO For Microbiota Restoration Therapy 10/11/2016
AngioSoma Files 3 New Patent Applications on Liprostin 10/11/2016
SkylineDx Receives Notice Of Allowance To Grant Patent For Prognostic SKY92 Gene Signature In Japan 10/11/2016